225 related articles for article (PubMed ID: 7274309)
1. Metabolism of estramustine phosphate (Estracyt) in patients with prostatic carcinoma.
Andersson SB; Gunnarsson PO; Nilsson T; Forshell GP
Eur J Drug Metab Pharmacokinet; 1981; 6(2):149-54. PubMed ID: 7274309
[TBL] [Abstract][Full Text] [Related]
2. Plasma concentrations of estramustine phosphate and its major metabolites in patients with prostatic carcinoma treated with different doses of estramustine phosphate (Estracyt).
Gunnarsson PO; Forshell GP; Fritjofsson A; Norlén BJ
Scand J Urol Nephrol; 1981; 15(3):201-5. PubMed ID: 7323739
[TBL] [Abstract][Full Text] [Related]
3. The absorption metabolism, and excretion of Estracyt (NSC 89199) in patients with prostatic cancer.
Forshell GP; Müntzing J; Ek A; Lindstedt E; Dencker H
Invest Urol; 1976 Sep; 14(2):128-31. PubMed ID: 972005
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of estramustine phosphate (Estracyt) in prostatic cancer patients.
Gunnarsson PO; Andersson SB; Johansson SA; Nilsson T; Plym-Forshell G
Eur J Clin Pharmacol; 1984; 26(1):113-9. PubMed ID: 6714283
[TBL] [Abstract][Full Text] [Related]
5. Estramustine phosphate: metabolic aspects related to its action in prostatic cancer.
Kadohama N; Kirdani RY; Murphy GP; Sandberg AA
J Urol; 1978 Feb; 119(2):234-9. PubMed ID: 633484
[TBL] [Abstract][Full Text] [Related]
6. Metabolic parameters of Estracyt pertinent to its effects in prostatic cancer.
Sandberg AA
Urology; 1984 Jun; 23(6 Suppl):11-21. PubMed ID: 6375075
[No Abstract] [Full Text] [Related]
7. Uptake of estramustine phosphate (estracyt) metabolites in prostatic cancer.
Norlén BJ; Andersson SB; Björk P; Gunnarsson PO; Fritjofsson A
J Urol; 1988 Nov; 140(5):1058-62. PubMed ID: 3172360
[TBL] [Abstract][Full Text] [Related]
8. [Estracyt (estradiol-nitrogen mustard complex)--estramustine binding protein and its specificity].
Yamanaka H; Imai K; Suzuki T; Yuasa H; Takahashi E
Gan To Kagaku Ryoho; 1984 Oct; 11(10):2106-14. PubMed ID: 6486830
[TBL] [Abstract][Full Text] [Related]
9. Effect of treatment with diethylstilbestrol-polyestradiol phosphate or estramustine phosphate (estracyt) on natural killer cell activity in patients with prostatic cancer.
Kalland T; Haukaas S
Invest Urol; 1981 May; 18(8):437-9. PubMed ID: 7228576
[TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacokinetics of estramustine phosphate.
Gunnarsson PO; Forshell GP
Urology; 1984 Jun; 23(6 Suppl):22-7. PubMed ID: 6375076
[No Abstract] [Full Text] [Related]
11. [Pharmacology and metabolism of a new therapeutic drug for prostatic cancer "Estracyt"].
Yamanaka H; Shida K
Gan To Kagaku Ryoho; 1984 Mar; 11(3):537-44. PubMed ID: 6422861
[TBL] [Abstract][Full Text] [Related]
12. Partial characterization and "quantitation" of a human prostatic estramustine-binding protein.
Björk P; Forsgren B; Gustafsson JA; Pousette A; Högberg B
Cancer Res; 1982 May; 42(5):1935-42. PubMed ID: 7066904
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer; plasma concentrations of estramustine phosphate and its metabolites.
Kirdani RY; Karr JP; Murphy GP; Sandberg AA
N Y State J Med; 1980 Aug; 80(9):1390-3. PubMed ID: 6938806
[No Abstract] [Full Text] [Related]
14. Treatment of prostatic carcinoma with various types of estrogen derivatives.
Jönsson G; Olsson AM; Luttrop W; Cekan Z; Purvis K; Diczfalusy E
Vitam Horm; 1975; 33():351-76. PubMed ID: 1229063
[TBL] [Abstract][Full Text] [Related]
15. Inhibition by estramustine phosphate on estradiol and androgen binding in benign and malignant prostate in humans.
Nilsson I; Liskowski L; Nilsson T
Urology; 1976 Aug; 8(2):118-21. PubMed ID: 60819
[TBL] [Abstract][Full Text] [Related]
16. The oestrogenic effects of ethinyl oestradiol/polyoestradiol phosphate and estramustine phosphate in patients with prostatic carcinoma. A comparative study of oestrogen sensitive liver proteins, gonadotrophins and prolactin.
Daehlin L; Damber JE; von Schoultz B; Bergman B
Br J Urol; 1986 Aug; 58(4):412-6. PubMed ID: 3092893
[TBL] [Abstract][Full Text] [Related]
17. The hydrolysis of estramustine phosphate; in vitro studies.
Gunnarsson O; Andersson SB; Johansson SA
Eur J Drug Metab Pharmacokinet; 1983; 8(4):395-402. PubMed ID: 6673977
[TBL] [Abstract][Full Text] [Related]
18. Studies on the conversion of oestradiol linked to a cytostatic agent (Estracyt) in various rat tissues.
Hoisaeter PA
Acta Endocrinol (Copenh); 1976 Jul; 82(3):661-72. PubMed ID: 947135
[TBL] [Abstract][Full Text] [Related]
19. Estramustine. Metabolic pattern and possible mechanisms for its action in prostate cancer.
Kadohama N; Kirdani RY; Madajewicz S; Murphy GP; Sandberg AA
N Y State J Med; 1979 Jun; 79(7):1005-9. PubMed ID: 287893
[No Abstract] [Full Text] [Related]
20. Differential uptake of estramustine phosphate metabolites and its correlation with the levels of estramustine binding protein in prostate tumor tissue.
Walz PH; Björk P; Gunnarsson PO; Edman K; Hartley-Asp B
Clin Cancer Res; 1998 Sep; 4(9):2079-84. PubMed ID: 9748122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
